4Qaqish RB, Mattes KA, Ritchie DJ. Adefovir dipivoxil, a new antiviral agent for the treatment of hepatitis B virus infection [J]. Clin Ther, 2003, 25(12): 3084-3099.
5Baker DE. Adefovir dipivoxil, focus on its use in the treat- ment of chronic hepatitis B [ J ]. Rev Gastroenterol Disord, 2005, 5(2) : 89 -100.
6Izzedine H, H ulot JS, Launay -Vacher V, et al. Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: two double - blind, randomized, placebo - controlled studies[ J ]. Kidney Int, 2004, 66(3),,1153 -1158.
8Wiegand J, Tischendorf J J, Nashan B. Severe exacerbation of chronic hepatitis B after emergence of lamivudine resist- ance in a cirrhotic patient: immediate switch to adefovir dip- ivoxil appears to be indicated [ J ]. Gastroenterol, 2004, 42 (1): 15 -18.
2Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量：1931
9Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14(9):643-646. 被引量：829
3KEEFFE EB, DIETERICH DT, HAN SH, et al. A treatment al- gorithm for the management of chronic hepatitis B virus in- fection in the United States:2008 update[ J]. Clin Gastroen- terol Hepatol, 2008, 6(12):1315-1341.
